ORGS (ORGENESIS INC)
Insider Trading Activity
Every open-market purchase and sale reported by ORGS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-25 | Vered Caplan | CEO & CHAIRMAN OF THE BOARD | A | — | — |
| 2024-07-25 | Ashish Nanda | Director | A | — | — |
| 2024-07-19 | Mark Goodman | Director | A | — | — |
| 2024-07-18 | Victor Miller | CHIEF FINANCIAL OFFICER | A | — | — |
| 2024-07-17 | Itzhak Vider | Director | A | — | — |
| 2024-04-02 | Victor Miller | Chief Financial Officer | M | — | — |
| 2024-02-14 | Jacob Safier | 10%+ Owner | Buy | — | — |
| 2024-02-14 | Jacob Safier | 10%+ Owner | Buy | — | — |
| 2024-01-08 | Victor Miller | CHIEF FINANCIAL OFFICER | A | — | — |
| 2023-12-21 | Ashish Nanda | Director | A | — | — |
| 2023-12-21 | Guy Yachin | Director | A | — | — |
| 2023-12-21 | DAVID SIDRANSKY | Director | A | — | — |
| 2023-12-21 | Yaron Adler | Director | A | — | — |
| 2023-12-21 | Mario Philips | Director | A | — | — |
| 2023-09-05 | Elliot Maltz | Chief Financial Officer | A | — | — |
| 2022-12-29 | Guy Yachin | Director | A | — | — |
| 2022-12-29 | DAVID SIDRANSKY | Director | A | — | — |
| 2022-12-29 | Mario Philips | Director | A | — | — |
| 2022-12-29 | Yaron Adler | Director | A | — | — |
| 2022-12-29 | Ashish Nanda | Director | A | — | — |
| 2022-06-16 | Vered Caplan | CEO and Chairman | A | — | — |
| 2022-06-16 | Kunik Efrat Assa | Chief Development Officer | A | — | — |
| 2022-06-16 | Neil Reithinger | CFO, Treasurer and Secretary | A | — | — |
| 2022-02-02 | Vered Caplan | Chief Executive Officer | M | — | — |
| 2021-01-11 | DAVID SIDRANSKY | Director | Buy | — | — |
| 2020-03-20 | Mario Philips | Director | A | — | — |
| 2020-03-20 | Guy Yachin | Director | A | — | — |
| 2020-03-20 | Neil Reithinger | CFO, Treasurer and Secretary | A | — | — |
| 2020-03-20 | Sarah Ferber | Chief Scientific Officer | A | — | — |
| 2020-03-20 | Vered Caplan | Chief Executive Officer | A | — | — |
| 2020-03-20 | DAVID SIDRANSKY | Director | A | — | — |
| 2020-03-20 | Yaron Adler | Director | A | — | — |
| 2020-03-20 | Ashish Nanda | Director | A | — | — |
| 2020-01-16 | DAVID SIDRANSKY | Director | A | — | — |
| 2020-01-16 | Ashish Nanda | Director | A | — | — |
| 2020-01-16 | Yaron Adler | Director | A | — | — |
| 2020-01-16 | Guy Yachin | Director | A | — | — |
| 2020-01-13 | Mario Philips | Director | A | — | — |
| 2019-03-05 | Neil Reithinger | CFO, Treasurer and Secretary | A | — | — |
| 2019-03-05 | Ashish Nanda | Director | A | — | — |
| 2019-03-05 | Denis Bedoret | See Remarks | A | — | — |
| 2019-03-05 | Vered Caplan | Chief Executive Officer | A | — | — |
| 2019-03-05 | DAVID SIDRANSKY | Director | A | — | — |
| 2019-03-05 | Yaron Adler | Director | C | — | — |
| 2019-03-05 | Guy Yachin | Director | A | — | — |
| 2018-11-05 | Guy Yachin | Director | A | — | — |
| 2018-11-05 | Sarah Ferber | Chief Scientific Officer | A | — | — |
| 2018-11-05 | DAVID SIDRANSKY | Director | A | — | — |
| 2018-11-05 | Yaron Adler | Director | A | — | — |
| 2018-10-25 | Sarah Ferber | Chief Scientific Officer | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 494,000 | — |
| — | — | 81,758 | — |
| — | CEO & CHAIRMAN OF THE BOARD | 27,819 | — |
| — | Director | 3,766 | — |
| — | CHIEF FINANCIAL OFFICER | 2,500 | — |
| — | Director | 18 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ORGS quote page; the site-wide leaderboard is on the insider transactions hub.